Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
International Journal of Pharmaceutics|February 11, 2014
PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in miceDhaval K Shah, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics|December 26, 2013
Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecanDhaval K Shah, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics|November 25, 2010
Physiologically based pharmacokinetic model for topotecan in miceDhaval K Shah, Joseph P Balthasar
Cancer Chemotherapy and Pharmacology|February 10, 2011
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancerDhaval K Shah, Jean Veith, Ralph J Bernacki, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2009
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapyDhaval K Shah, Beom Soo Shin, Jean Veith, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 17, 2015
Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeuticsDhaval K Shah
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasmaJin Chen, Joseph P Balthasar
Biomolecules|October 18, 2018
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human TissuesTommy Li, Joseph P Balthasar
The AAPS Journal|July 29, 2009
Investigation of the influence of FcRn on the distribution of IgG to the brainAmit Garg, Joseph P Balthasar
Pageof 20